Re: FW: transit model

From: Sébastien Bihorel Date: August 27, 2008 technical Source: mail-archive.com
Dirk, This absorption can correctly accommodate multiple dosing only if the absorption of dose n is complete when dose n+1 is given ! Since the input is hard-coded and reset at each dose, you have to make sure that the estimate you get for MTT and NN provide this complete absorption. Otherwise, part of each dose does never enter the system. I don't really understand how you implemented the transit model but you may refer to the following code (for Wings for NONMEM) that worked just fine for me. The frame for the input function has to start at zero to I used a time transform based on a dosing interval of 24h. A column DAY is included in the dataset to calculate the new time MYT. Hope it helps. Sebastien Bihorel $PROBLEM Simulation Transit model $INPUT ID DOSE DAY TI24 TIME AMT RATX CMT EVID DVID DV MDV $DATA ../Data/Simulation.csv IGNORE=# $SIM (32047023) NSUB=1 $SUB ADVAN6 TOL3 $THETA (0,6.) ; POP_CL $THETA (0,100.) ; POP_V2 $THETA (0,18.) ; POP_MTT $THETA (0.00001,3.) ; POP_n $THETA (0,6.) ; POP_TABS $OMEGA BLOCK(2) 0.1 ; BSVCL 0.01 0.1 ; BSVV2 $OMEGA BLOCK(3) 0.1 ; BSVMTT 0.01 0.1 ; BSVN 0.01 0.01 0.1 ; BSVTABS $SIGMA 0.1 ;cvcp $SIGMA 0.05 ;sdcp $MODEL COMP = (ABS) ; absorption compartment COMP = (CEN) ; central compartment ;$ABBREVIATED DERIV2=NOCOMMON $PK "FIRST " COMMON /PRCOMG/ IDUM1,IDUM2,IMAX,IDUM4,IDUM5 " INTEGER IDUM1,IDUM2,IMAX,IDUM4,IDUM5 " IMAX=1000000 IF(AMT.GT.0.AND.CMT.EQ.1)PODO=AMT; oral dose F1 = 0. F2 = 0. ECL = EXP(BSVCL) EV2 = EXP(BSVV2) EMTT = EXP(BSVMTT) ENB = EXP(BSVN) ETAB = EXP(BSVTABS) CL = POP_CL * ECL V = POP_V2 * EV2 MTT = (POP_MTT * EMTT)/60 NB = POP_n * ENB TABS = POP_TABS * ETAB KA = LOG(2)/(TABS/60) KTR = (NB+1)/MTT ; transit rate constant LNFA = 0.5*LOG(2*3.14159*NB)+NB*LOG(NB)-NB+LOG(1.+1./(12.*NB)) ; logarithmic transformation of 2nd Stirling approximation S2 = V BIO =1. $DES MYT = T -(DAY-1)*24 IF (MYT.LT.0.001) THEN INPU = 0. ELSE INPU = EXP(LOG(BIO*PODO)+LOG(KTR)+NB*LOG(KTR*MYT)-KTR*MYT-LNFA) ENDIF DADT(1) = INPU-KA*A(1) DADT(2) = (KA*A(1)-CL*A(2))/V $ERROR CP=A(2) Y=CP*(1+CVCP)+SDCP $TABLE ID DAY TIME AMT CMT EVID DVID Y CL V MTT NB TABS ECL EV2 EMTT ENB ETAB ONEHEADER NOPRINT FILE=k0ka1l.fit Garmann Dirk a écrit : > Dear NONMEM users, > > I try to fit a dataset with a high variability in TLAG. With the standard approaches it was not possible to get successful runs (variability in Tlag is always modeled as zero, but their is clearly a high variability) > > Therefore I used the transit model, published by Justin Wilkins/Radoika Savic. For single dose studies it works well (improved fit/successful runs). Next , I included a multiple drug study and adapted the model. The model works, but I have some questions regarding the code (see below in red). It would be very nice if someone can help to enhance my understanding. > > Thank you in advance > > Dirk > > $SUBROUTINE ADVAN6 TOL=3 > > $MODEL NCOMP=3 COMP=(DEPOT) COMP=(CENTRAL,DEFOBS) COMP=(PERIPH) > > $PK > > "FIRST > > " COMMON /PRCOMG/ IDUM1,IDUM2,IMAX,IDUM4,IDUM5 > > " INTEGER IDUM1,IDUM2,IMAX,IDUM4,IDUM5 > > " IMAX=9900000 > > IF(AMT.GT.0.AND.CMT.EQ.1) PD=AMT > > IF(AMT.GT.0) TDOS=TIME > > TVCL=THETA(1) > > CL=TVCL*EXP(ETA(1)) > > TVV2=THETA(2) > > V2=TVV2*EXP(ETA(2)) > > TVV3=THETA(3) > > V3=TVV3*EXP(ETA(3)) > > TVQ=THETA(4) > > Q=TVQ*EXP(ETA(4)) > > ; Absorption model > > ;F1=0 delete NONMEMS Dose record > > F1=0 > > TVKA=THETA(5) > > KA=TVKA*EXP(ETA(5)) > > ;Mean transit time > > TVMTT=THETA(6) > > MTT=TVMTT*EXP(ETA(6)) > > ;Number of transit compartments > > TVNN=THETA(7) > > NN=TVNN*EXP(ETA(7)) > > ;Transit rate constant > > KTR=(NN+1)/MTT > > ;Sterling > > L=LOG(2.5066)+(NN+.5)*LOG(NN)-NN > > S2=V2/1000 > > ; DOSE : mg > > ; CONC: ng/ml > > $DES > > X=0.00001; Avoid LOG 0 > > ;multiple dose > > IF(T.GE.TDOS)THEN ; if current time greater than TDOS > > *Is this correct? I think GE might be a typo and should be GT?* > > * * > > DADT(1) = EXP(LOG(PD + X) + LOG(KTR + X)+NN*LOG(KTR*(T-TDOS)+X)-KTR*(T-TDOS)-L)-KA*A(1) > > ELSE > > ; Dose given > > DADT(1) = EXP(LOG(PD + X) + LOG(KTR + X)+ NN*LOG(KTR*T + X) - KTR*T - L)- KA*A(1) > > ENDIF > > *T.GE.TDOS (see above) might be a typo; otherwise this equation will never be active?* > > *I try this model with GT, the fit improves, but why is this statement needed?* > > * * > > *Can someone explain this (red) part of the equation, please? * > > *I think if the time is e.g. 24 hours (time of second dose) the value of the input function will be low, as it should be to simulate the lag time (I used MTT=1, NN=4, to recalculate it). With further increased time (next doses), the value of the input function will be approximately zero (ok). * > > * * > > *But _without_ this equation and * > > *IF(AMT.GT.0.AND.CMT.EQ.1) PD=AMT* > > *IF(AMT.GT.0) TDOS=TIME* > > * * > > *(T-TDOS) should be zero * *at each dose event* *and the value of the input function at a new dose event is also approximately zero (same as above?)* > > * * > > *Any help to enhance my understanding is welcome* > > DADT(2)=KA*A(1)-Q/V2*A(2)+Q/V3*A(3)-CL/V2*A(2) > > DADT(3)=Q/V2*A(2)-Q/V3*A(3) > > $ERROR > > *One last question:* > > *For some subjects I got some bizarre estimation values. I think this might be because I have sometimes dose events, but no observations (multiple dose study) prior to the next dose.. Therefore, if I correctly understand the code, the input value for these dose events will be approximately zero.* > > * * > > *Any suggestions to solve this problem are welcome.* > > ** > > *Best regards* > > *Dirk Garmann* > > ------------------------------------------------------------------------ > > SCHWARZ BIOSCIENCES GmbH > A Member of the UCB Group > Alfred-Nobel-Str. 10 - 40789 Monheim - Germany > Tel +49 2173 48 0 - Fax +49 2173 48 1608 > Geschaeftsfuehrer: Prof. Dr. Iris Loew-Friedrich, Detlef Thielgen > Amtsgericht Duesseldorf HRB 46849 > ------------------------------------------------------------------------ > > Legal Notice: This electronic mail and its attachments are intended solely for the person(s) to whom they are addressed and contain information which is confidential or otherwise protected from disclosure, except for the purpose for which they are intended. Dissemination, distribution, or reproduction by anyone other than the intended recipients is prohibited and may be illegal. If you are not an intended recipient, please immediately inform the sender and return the electronic mail and its attachments and destroy any copies which may be in your possession. UCB screens electronic mails for viruses but does not warrant that this electronic mail is free of any viruses. UCB accepts no liability for any damage caused by any virus transmitted by this electronic mail. (Ref: #*BG0508) > >
Aug 26, 2008 Garmann Dirk FW: transit model
Aug 27, 2008 Sébastien Bihorel Re: FW: transit model
Sep 05, 2008 Justin Wilkins Re: FW: transit model
Sep 05, 2008 Justin . Wilkins Re: FW: transit model